Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.

Joyce O’Shaughnessy(Baylor University Medical Center), Daniel D. Von Hoff(Translational Genomics Research Institute), Andrew J. Dannenberg(BioVentures (United States)), Monica M. Bertagnolli(National Institutes of Health), William G. Nelson(Johns Hopkins University), Lee W. Wattenberg(Twin Cities Orthopedics), Anil K. Rustgi(Columbia University Irving Medical Center), Michele Follen, Vali Papadimitrakopoulou(Novartis (Switzerland)), Gary J. Kelloff(Unknown), Adi F. Gazdar(Weatherford College), Carol J. Fabian(Washington Hospital), Caroline C. Sigman, Frank L. Meyskens(University of California, Irvine), Scott M. Lippman(UC San Diego Health System), Steven P. Stratton, Michael B. Sporn(Dartmouth College), David S. Alberts(University of Arizona), Waun Ki Hong(Shenzhen Nanshan Center for Chronic Disease Control), Gary Gordon, Stephen Lam(University of British Columbia), Wael Sakr(Wayne State University), Peter T. Scardino(Memorial Sloan Kettering Cancer Center)
PubMed
February 1, 2002
Cited by 383


Related Papers